News


    Katherine Wen is a doctoral student in the Department of Policy Analysis at Cornell University. Ms. Wen is working with CHERISH Research Affiliate and Cycle 1 Pilot Grant recipient, Dr. Yuhua Bao, to assess the effects of state policies and practices aimed at improving prescriber use of Prescription Drug Monitoring Programs (PDMPs) on opioid prescriptions […]

    Read the full story

    The National Institute on Drug Abuse (NIDA) will collaborate with the Substance Abuse and Mental Health Services Administration to initiate the HEALing Communities Study as part of the National Institute of Health HEAL initiative . The HEALing Communities study is a multi-site national research effort that aims to develop and implement evidence-based interventions to prevent […]

    Read the full story

    June 21, 2018

    The National Institutes of Health (NIH) announced the Helping to End Addiction Long-Term (HEAL) Initiative in spring 2018. This trans-NIH initiative will provide an additional $500 million in funding. The HEAL initiative will target two priority areas for research: to improve treatments for opioid misuse and addiction and to enhance pain management. The initiative will […]

    Read the full story

    Tyler Bartholomew is a doctoral student in the Department of Public Health Sciences at the University of Miami. Prior to entering the doctoral program, he was the project manager for an HIV and HCV testing, linkage to care, and treatment program at five federally-qualified health centers in Philadelphia, Pennsylvania as part of his AmeriCorps service. […]

    Read the full story

    On March 19, researchers from institutions across the country joined CHERISH leaders Bruce Schackman, Kathryn McCollister, Benjamin Linas and Sean Murphy for a daylong CHERISH introductory training to economic evaluations. Dr. Schackman began the day by introducing CHERISH to the attendees, who represented more than 25 institutions across New England, the Midwest, the Mid-Atlantic, the South […]

    Read the full story

    Hepatitis C Virus (HCV) is one of the leading causes of infectious disease deaths in the United States. Injection drug use is a common route of HCV transmission and the annual number of reported cases continues to rise due to the opioid epidemic. Previous HCV treatment regimens had severe side effects and limited efficacy, but […]

    Read the full story